Translation Validation of Advanced Compiler Optimizations

高级编译器优化的翻译验证

基本信息

  • 批准号:
    0456163
  • 负责人:
  • 金额:
    $ 11.38万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
    Continuing Grant
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-08-15 至 2006-05-31
  • 项目状态:
    已结题

项目摘要

ABSTRACT0306538Zuck, Lenore D.New York UniversityThe is a continuation of a project whose ultimate goal is to develop amethodology for the translation validation of advanced optimizing compilers, with an emphasis on EPIC-targeted compilers and the aggressive optimizations characteristic to such compilers. The methods developed will handle an extensive set of optimizations and could be used to implement fully automatic certifiers for a wide range of compilers.Previous work has developed:1. the theory of a "correct translation"; 2. a general proof rule for translation validation of "structure preserving" optimizations;3. TVOC -- a tool that implements the proof rule on an EPIC compiler (SGI Pro-64) and sends the proof obligations to be verified by a theorem prover (SRI's ICS.) 4. a proof rule for dealing with many "structure modifying" transformations, mostly loop optimizations; The proposed work extends the previous work as follows:1.develop the theory, and the supporting tools, that deal with inter- and intra-procedural optimizations. 2. build a special-purpose theorem prover will be built on top of CVC that will be tailored to handle the verification conditions generated by the methodology.3. identify and construct run-time checks of speculative optimizations. In addition, it will perform a compile-time validation of the transformation.4.Extend scoppe of project to machine-dependent optimizations, involving instruction scheduling and (software as well as hardware) pipelining. This project will provide a major step towards ensuring an extremely high level of confidence in compilers in areas, such as safety-critical systems and compilation into silicon, where correctness is of paramount concern.
摘要0306538Zuck,Lenore D.纽约大学这是一个项目的延续,其最终目标是开发高级优化编译器的翻译验证方法,重点是针对 EPIC 的编译器以及此类编译器的积极优化特性。 开发的方法将处理大量的优化,并可用于为各种编译器实现全自动验证器。以前的工作已经开发:1。 “正确翻译”理论; 2.“结构保持”优化翻译验证的通用证明规则;3. TVOC——一种在 EPIC 编译器(SGI Pro-64)上实现证明规则并发送证明义务以供定理证明者(SRI 的 ICS)验证的工具。 4. 用于处理许多“结构修改”转换(主要是循环优化)的证明规则;所提出的工作扩展了之前的工作如下: 1.开发处理过程间和过程内优化的理论和支持工具。 2. 构建一个专用定理证明器,该定理证明器将构建在 CVC 之上,该定理证明器将被定制以处理该方法生成的验证条件。3.识别并构建推测优化的运行时检查。 此外,它将执行转换的编译时验证。4.将项目范围扩展到机器相关的优化,包括指令调度和(软件以及硬件)流水线。 该项目将向确保编译器在安全关键系统和编译到芯片等领域的极高信心迈出重要一步,在这些领域,正确性是最重要的。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Lenore Zuck其他文献

Liveness with invisible ranking

Lenore Zuck的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Lenore Zuck', 18)}}的其他基金

EAGER: A Roadmap for research towards verification of NextG technologies
EAGER:NextG 技术验证研究路线图
  • 批准号:
    2140207
  • 财政年份:
    2021
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant
FMitF: Track I: Injecting Formal Methods into Internet Standardization
FMITF:第一轨:将形式化方法注入互联网标准化
  • 批准号:
    1918429
  • 财政年份:
    2019
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant
SHF: Medium: Self-certifying Compilation and its Applications
SHF:Medium:自认证编译及其应用
  • 批准号:
    1564296
  • 财政年份:
    2016
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant
Midwest Verification Day (MVD) 2013
2013 年中西部验证日 (MVD)
  • 批准号:
    1341855
  • 财政年份:
    2013
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant
TWC: Medium: Collaborative: Foundations of Application-Sensitive Access Control Evaluation
TWC:媒介:协作:应用程序敏感的访问控制评估的基础
  • 批准号:
    1228947
  • 财政年份:
    2012
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant
EAGER: From Devlopment Tools to Secure Web Applications
EAGER:从开发工具到安全 Web 应用程序
  • 批准号:
    1141863
  • 财政年份:
    2011
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant
Translation Validation of Advanced Compiler Optimizations
高级编译器优化的翻译验证
  • 批准号:
    0306538
  • 财政年份:
    2003
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Continuing Grant
CCR: The First Annual Conference on Verification, Model Checking and Abstract Interpretation 2003
CCR:2003 年第一届验证、模型检查和摘要解释年会
  • 批准号:
    0223760
  • 财政年份:
    2002
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant
Translation Validation of Advanced Compiler Optimizations
高级编译器优化的翻译验证
  • 批准号:
    0098299
  • 财政年份:
    2001
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant
Applications of Knowledge Theory to Distributed Systems
知识论在分布式系统中的应用
  • 批准号:
    8910289
  • 财政年份:
    1989
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant

相似海外基金

Development and validation of a research support system for Advanced Practice Nurses
高级执业护士研究支持系统的开发和验证
  • 批准号:
    23K09853
  • 财政年份:
    2023
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
I-Corps: Advanced simulation system for end-to-end autonomy validation in robot vehicle systems
I-Corps:用于机器人车辆系统端到端自主验证的高级仿真系统
  • 批准号:
    2331047
  • 财政年份:
    2023
  • 资助金额:
    $ 11.38万
  • 项目类别:
    Standard Grant
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10409385
  • 财政年份:
    2022
  • 资助金额:
    $ 11.38万
  • 项目类别:
Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced Cancers
游离 DNA 浅全基因组测序的测定验证以确定晚期癌症的“肿瘤部分”
  • 批准号:
    10706596
  • 财政年份:
    2022
  • 资助金额:
    $ 11.38万
  • 项目类别:
Validation of blood-based predictive biomarkers of therapeutic response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
局部晚期直肠癌患者新辅助放化疗治疗反应的血液预测生物标志物的验证
  • 批准号:
    10448869
  • 财政年份:
    2022
  • 资助金额:
    $ 11.38万
  • 项目类别:
Validation of blood-based predictive biomarkers of therapeutic response to neoadjuvant chemoradiation therapy in patients with locally advanced rectal cancer
局部晚期直肠癌患者新辅助放化疗治疗反应的血液预测生物标志物的验证
  • 批准号:
    10615862
  • 财政年份:
    2022
  • 资助金额:
    $ 11.38万
  • 项目类别:
Analytic and Clinical Validation of a 7-plex MIF Assay for Predictive Response of Advanced NSCLC to Anti-PD-1 based Therapy
7 重 MIF 检测对晚期 NSCLC 对抗 PD-1 治疗的预测反应的分析和临床验证
  • 批准号:
    10506186
  • 财政年份:
    2022
  • 资助金额:
    $ 11.38万
  • 项目类别:
Advanced development and validation of an in vitro platform to phenotype brain metastatic tumor cells using artificial intelligence
使用人工智能对脑转移肿瘤细胞进行表型分析的体外平台的高级开发和验证
  • 批准号:
    10630975
  • 财政年份:
    2022
  • 资助金额:
    $ 11.38万
  • 项目类别:
Assay Validation of Cell-Free DNA Shallow Whole Genome Sequencing To Determine 'Tumor Fraction' in Advanced Cancers
游离 DNA 浅全基因组测序的测定验证以确定晚期癌症的“肿瘤部分”
  • 批准号:
    10661868
  • 财政年份:
    2022
  • 资助金额:
    $ 11.38万
  • 项目类别:
Analytic and Clinical Validation of a 7-plex MIF Assay for Predictive Response of Advanced NSCLC to Anti-PD-1 based Therapy
7 重 MIF 检测对晚期 NSCLC 对抗 PD-1 治疗的预测反应的分析和临床验证
  • 批准号:
    10705736
  • 财政年份:
    2022
  • 资助金额:
    $ 11.38万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了